» Articles » PMID: 29082258

The Impact of Ghrelin in Metabolic Diseases: An Immune Perspective

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2017 Oct 31
PMID 29082258
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and insulin resistance have reached epidemic proportions. Obesogenic conditions are associated with increased risk for the development of other comorbidities and obesity-related diseases. In metabolic disorders, there is chronic low-grade inflammation induced by the activation of immune cells, especially in metabolic relevant organs such as white adipose tissue (WAT). These immune cells are regulated by environmental and systemic cues. Ghrelin is a peptide secreted mainly by X/A-like gastric cells and acts through the growth hormone secretagogue receptor (GHS-R). This receptor is broadly expressed in the central nervous system (CNS) and in several cell types, including immune cells. Studies show that ghrelin induces an orexigenic state, and there is increasing evidence implicating an immunoregulatory role for ghrelin. Ghrelin mainly acts on the innate and adaptive immune systems to suppress inflammation and induce an anti-inflammatory profile. In this review, we discuss the immunoregulatory roles of ghrelin, the mechanisms by which ghrelin acts and potential pharmacological applications for ghrelin in the treatment of obesity-associated inflammatory diseases, such as type 2 diabetes (T2D).

Citing Articles

Anamorelin Efficacy in Non-Small-Cell Lung Cancer Patients With Cachexia: Insights From ROMANA 1 and ROMANA 2.

Laird B, Skipworth R, Bonomi P, Fallon M, Kaasa S, Giorgino R J Cachexia Sarcopenia Muscle. 2025; 16(1):e13732.

PMID: 39992021 PMC: 11848863. DOI: 10.1002/jcsm.13732.


Insulin resistance-related circulating predictive markers in the metabolic syndrome: a systematic review in the Iranian population.

Zahedi A, Zarkesh M, Sedaghati-Khayat B, Hedayati M, Azizi F, Daneshpour M J Diabetes Metab Disord. 2024; 23(1):199-213.

PMID: 38932859 PMC: 11196549. DOI: 10.1007/s40200-023-01347-6.


Salivary α-amylase activity is associated with cardiometabolic and inflammatory biomarkers in overweight/obese, non-diabetic Qatari women.

Al Akl N, Khalifa O, Habibullah M, Arredouani A Front Endocrinol (Lausanne). 2024; 15:1348853.

PMID: 38562410 PMC: 10982335. DOI: 10.3389/fendo.2024.1348853.


Immunomodulatory role of vasoactive intestinal peptide and ghrelin in .

Munoz-Flores C, Roa F, Saavedra P, Fuentealba P, Starck M, Ortega L Heliyon. 2023; 9(12):e23215.

PMID: 38149209 PMC: 10750074. DOI: 10.1016/j.heliyon.2023.e23215.


Ghrelin hormone a new molecular modulator between obesity and glomerular damage.

Ibrahim M, Khalife L, Abdel-Latif R, Faour W Mol Biol Rep. 2023; 50(12):10525-10533.

PMID: 37924451 DOI: 10.1007/s11033-023-08866-8.


References
1.
Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K, Kojima M . Structure, regulation and function of ghrelin. J Biochem. 2011; 151(2):119-28. DOI: 10.1093/jb/mvr134. View

2.
Camilleri M, Papathanasopoulos A, Odunsi S . Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009; 6(6):343-52. PMC: 3898933. DOI: 10.1038/nrgastro.2009.72. View

3.
Li B, Zeng M, Zheng H, Huang C, He W, Lu G . Effects of ghrelin on the apoptosis of human neutrophils in vitro. Int J Mol Med. 2016; 38(3):794-802. PMC: 4990324. DOI: 10.3892/ijmm.2016.2668. View

4.
Choe S, Huh J, Hwang I, Kim J, Kim J . Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne). 2016; 7:30. PMC: 4829583. DOI: 10.3389/fendo.2016.00030. View

5.
Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra D . Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009; 29(2):359-70. PMC: 6664935. DOI: 10.1523/JNEUROSCI.2760-08.2009. View